#VWS Experience Shared
Past Advisory Board Members
Dr Ranjan Chakrabarthi
Former Vice President, Global Biologics United States Pharmacopeia
Dr. Milind Gore
(Former) Emeritus Scientist G, National Institute of Virology
Dr Ivana Haluskova
Vaccines Industry Expert
Dr Dhananjay Patankar
Dr. Kate O’Brien, MD, MPH
Director – Immunization, Vaccines & Biologicals Department (IVB), World Health Organization
Dr Kate O’Brien is Director of the Immunization, Vaccines and Biologicals Department at the World Health Organization. In this role she is responsible for leading WHO’s strategy and implementation to advance the vision of a world where everyone, everywhere, at every age, fully benefits from vaccines for good health and wellbeing. Dr O’Brien also serves as WHO’s Technical Lead of the COVID Vaccine Pillar (COVAX), a part of the Access to COVID Tools Accelerator (ACT-A). COVAX aims to support countries to achieve their goals toward the Global COVID-19 Vaccine Strategy for 2022, released by WHO and the UN Secretary General in October 2021. It establishes the health, social and economic goals of the vaccine effort and establishes a target of 70% full vaccine coverage by mid-2022.
Dr O’Brien is a Canadian who trained as a pediatric infectious disease physician, epidemiologist and vaccinologist. She earned her BSc in chemistry from University of Toronto (Canada), her MD from McGill University (Canada), and her MPH from Johns Hopkins Bloomberg School of Public Health (USA).
Dr. Bakulesh Khamar
ED, Cadila Pharmaceuticals Ltd
Dr GVJA Harshvardhan
Executive Director, Indian Vaccine Maunfacturers Association and Consultant, Bharat Biotech International Ltd.
Dr. Jaby Jacob
Head Research & Development, Bharat Serums & Vaccines (BSV)
Dr Kutub Mahmood
Scientific Director, Path
Dr Preetha Rajaraman
U.S Health Attache, India & Regional Representative, South Asia-Office of Global Affairs, DHHS
Dr Sandeep Majumdar
SVP, Operations Biologics, Intas Pharmaceuticals Ltd.
Dr Sarah McMullen
Country Director, USFDA
Dr Shirshendu Mukherjee
Mission Director , Grand Challenges India ,Jointly Supported by DBT-BIRAC-BMGF-Wellcome Trust, BIRAC
Dr SK Jana
Director, R&D & Manufacturing, Serum Institute of India
Dr Sudeep Kumar
SVP, Biological E Ltd.
Dr Vibha Jawa
Executive Director, Bristol Myers Squibb
Dr Vipul Doshi
Group Quality Assurance and Regulatory, Zydus Lifesciences Ltd
Senior Vice President & Global Head – Supply Chain Management, Central Engineering, Biocon Ltd
Prof. Rahul Purwar
Department of Biosciences & Bioengineering IIT Bombay and Founder & CEO ImmunoACT
Rajinder Kumar Suri
CEO, Developing Countries Vaccine Manufacturers' Network (DCVMN)
President & Head, BU Biologics, Zydus Lifesciences Ltd
Dr. Abhishek Mathur
Dr. Abhishek Mathur, Chief Scientific Officer, Biolexis- Strides Biopharma Pvt. Ltd., India
Abhishek Mathur is currently working as a Director of Global Research (Biologics) for Amgen and is based on California, USA. In his role, he supports external innovation for Amgen by tapping into novel and innovative technologies that are being developed & commercialized by niche suppliers, and via establishing key external partnerships in support of Amgen drug discovery pipeline.
Abhishek has over 15 years of experience in leading CMC functions and has successfully led multiple Innovator Biologics & Biosimilar programs from preclinical stage through commercialization while working with top tier biopharma companies like Amgen and Regeneron. Abhishek holds PhD in Biological Sciences from Northwestern University, Bachelors of Technology in Chemical Engineering from IIT Bombay and an MBA from Duke University.
Dr Ajitkumar K Sudke
Lead Technical Hub, Population Services International,
Dr Ashish Sahai
Additional Director, Viral Vaccine Production, Serum Institute of India Pvt. Ltd
Dr Anurag . S Rathore
Coordinator, DBT Center of Excellence for Biopharmaceutical Technology and Professor, Department of Chemical Engineering, Indian Institute of Technology
Dr A Ramkishan
Deputy Drugs Controller (India), CDSCO East Zone Kolkata, DGHS, Ministry of Health & Family Welfare
Dr Dhananjay Patankar
Dr Elena Smith
Deputy Director, Analytical Expert - Quality, Sanofi
Dr Farshad Guirakhoo
Chief Scientific Officer, Vaxxinity
Dr. Indrapal Reddy Addela,
Senior Vice President - Operations, Lazuline Biotech
Dr Jayanta Bhattacharya
Director, Adjunct Faculty & PI, Translational Health Science & Technology Institute | Department of Biotechnology, IAVI – India HIV Vaccine Translational Research Laboratory
Dr Manoj Chhikara
Vacccines R&D Expert
Dr. Milind Gore
(Former) Emeritus Scientist G, National Institute of Virology
Dr. Niraj V Shende
Manager, Analytical Chemistry Lab, Serum Institute of India, SEZ
Dr Ranjan Chakrabarthi
Former Vice President, Global Biologics United States Pharmacopeia
Dr Ravi Prakash Mathur
Vice President and Global Head of Logistics and Supply Chain Excellence
Dr Raj Shankar Ghosh
Senior Advisor, Vaccine Delivery, Bill & Melinda Gates Foundation
Dr Ratnesh Jain
Course Co-ordinator- Bioprocess Technology & Innovation Ambassador, Institute of Chemical Technology
Dr Ravi Ganapathy
Director – CMC & R&D, Hilleman Laboratories
Dr Sanjeev Gupta, Ph.D.,
President and Head-Advanced BioTech (Biosimilar Division), Ipca Laboratories Ltd,
Dr Shaligram Rane
VP-Quality, Lupin Ltd.
Dr Shashwati Basak Phd
Biopharma Professional, Expert In Cell And Gene Therapy
Dr Shashwati Basak has a PhD in Molecular and Cell Biology and two postdoctoral fellowships in gene expression, regulation and cancer signalling pathways from Salk Institute for Biological Sciences and Stanford University. She has 20+ years of scientific leadership experience in translational research, clinical biomarkers, analytical assays and technology platforms. She has worked in several Biotech / Biopharma companies including Biocon Bristol Myers-Squibb R & D center, Aurigene Discovery Technologies and Immuneel Therapeutics Ltd and held positions of increasing responsibilities, in varied roles. Currently, as an Independent Consultant, her focus is on various aspects of drug development, especially in Cell and Gene Therapy, including Quality and Compliance in CGT.
Dr Sunil Gairola
Executive Director, Serum Institute of India Pvt.,Ltd
Dr. Sumeet Juneja
Technical Specialist (Immunization), Population Services International
Dr Subhadeep Sinha
Senior Vice President, Global Head-Clinical Research, Pharmacovigilance & Medical Affairs - Hetero Drugs Ltd
Dr Sudarshan Reddy
Founder & CEO, Oncosimis Biotech Pvt Ltd
Dr Sumant Karnik
Advisor Haffkine Institute for Testing, Research & Training
Dr Suresh Beri, Addnl.
Director, Serum Institute of India Pvt., Ltd.
Dr Upendra Jani
Consultant Microbiologist, Hester Biosciences Ltd
Dr Vasan Sambandamurthy
SVP-Global Operation Bugworks Research Inc
Technical Key Account, Datwyler Healthcare
Global Technical Developer, Roquette India Pvt. Ltd.
Senior Contracts Manager, Covid-19 Response, UNICEF
Plant Head-Sterile Injectables, Lupin Pharmaceuticals Ltd
AGM, Panacea Biotech
Global Business Director, Croda International Plc
Peter Holm Tygesen is an organic chemist by training. He has more than 30 years of pharmaceutical management experience. Notably he has worked at Lundbeck for more than 13 years in different positions in R&D and production management. He has also served as CEO of the Biotech company Egalet and Riemann before becoming the CEO of Biosector Brenntag, and successfully led the integration of Biosector as Managing Director Croda Denmark after the acquisition by Croda International Plc. Most recently he assumed the role of Global Business Director for Croda’s Vaccine Adjuvant Systems platform within Croda Pharma. He excels in driving change management and in interacting with partners and authorities.
Prof. S.S. Vasan
University of York
Technical Account Specialist,West Pharmaceutical Services
Biopharma Consultant, Ami Polymer Pvt.Ltd
R. Chandi Prasad
Head-Packaging Development, Aurobindo Pharma Ltd.
Senior Research Fellow, Communicable Diseases, Interactive Research School for Health Affairs, Bharati Vidyapeeth
CEO, Clonz Biotech Pvt. Ltd.
Strategic Marketing Manager-Separation Technology Business, Sartorius Stedium Biotech
CMC Lead, Europe, CEPI (Coalition For Epidemic Preparedness Innovations)
Regional BDM, APAC- Pall Corporation
Attendees Representing Vaccine Manufacturers, Institutes, Regulators
Companies From India, China, Africa, Brazil, Russia And More!
Speakers Sharing Their Expertise
In-Person Networking Hours
The Vaccines World Summit 2022 is the only vaccine conference dedicated to the Asia Pacific vaccine manufacturing sector. This event connects leaders in manufacturing, R&D and supply chain from vaccine manufacturing companies to debate best practices in vaccine manufacturing in Asia, share intelligence and network.
Addressing key hurdles to achieving rapid time to market efficiently, the conference illuminates the road forward for data usage, software and innovative solutions.
Vaccination programs save millions of lives each year globally. With more than 100 million children immunized each year, global immunization coverage has never been higher. Sources indicate that the worldwide market for vaccines is expected to reach USD 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3% from 2016 to 2021. The key drivers driving the growth of this market are a high prevalence of diseases, rising government and nongovernment funding for vaccine development, increasing investments by companies, and increasing focus on immunization programs. With factors such as advances in immunology, genetics, and vaccine technology as well as increased demand from population growth in emerging economies, the global vaccine market is expected to surpass an estimated USD 100 billion by 2025. The economies of developing countries, for example, India is growing at a tremendous speed, and it is expected to grow 10-15% within the next decade. Emerging manufacturers play a critical role in the supply of vaccines of developing countries, particularly basic and some combination vaccines. 30% of UNICEF’s total procurement comes from emerging manufacturers. The decrease in vaccine prices can also be attributed to increased competition and higher production capacities for individual vaccines brought about by the entry of emerging market manufacturers, particularly in the underused vaccines market. Vaccines World Summit, for developing economies, aims to bring together key experts and decision-makers from vaccine manufacturers, governmental organizations, regulators, non-profit organizations, and solution providers together to aid in advancements in this industry with significantly higher collaboration.
COVID-19 Vaccine Action Plan in Asian Countries
Effective Strategies to Produce and Manufacture COVID-19 Vaccine at Scale and Pace
Ramping Up COVID-19 Vaccine Fill & Finish Capacity
Vaccines for Emerging Viral Diseases
Clinical Trial Results from Next- Gen and New Pipelines in the Industry
New Approaches to Evaluating Vaccine Quality Control & Safety
Production and Tech Transfers to Speed Up Local Vaccine Production
Whole-Microbe & Genetic Approach of Vaccine Development
The Way Forward for Vaccine Development and the Challenges Ahead
JNC CORPORATION / MR SANGHAVI & CO. We are in the business of providing Biotech, Pharma, Fine Chemicals & Academia solutions. With state of the art chromatography bulk media, resins, gels & equipment’s from the world’s best companies, we offer the best technical solutions & support. The Cellufine™ product line offers a broad range of chromatography resins for the purification of proteins, enzymes, and biomolecules. The media based on spherical cellulose beads, exhibits high chemical stability / mechanical strength, higher flux and inherently bio-compatible. Applications include protein / polysaccharide purification, endotoxin removal, and used worldwide purifying vaccines, therapeutic enzymes, and virus concentration / purification. Cellulose media have significantly lower Leachable than comparable polymeric beads. Gel Filtration, IEX, Affinity, and HIC media available for broad range of biomolecules and applications. Cellufine customizes media / ligands, bead sizes for challenging purification process. Besides growing and consolidating the business of international marketing of industrial products and chemical specialties, we undertake backward/forward integration activity to produce tailor-made value-added specialty products. “Our mission is to become a benchmark organization in this line of business by striving consistently to develop our organization, professional skills & infrastructure as to be highly effective in this competitive environment.” Mr. Rajiv Sanghavi Director JNC CORPORATION/MR SANGHAVI & CO. 28, Sarvodaya Industrial Estate, Near Paper Box, Off. Mahakali Caves road, Andheri East, Mumbai – 400093 Mobile : +91-9323990409 Email : firstname.lastname@example.org Website : www.mrsanghavico.com
Pall Corporation provides critical filtration, separation, and purification solutions to meet the demanding needs of a broad spectrum of life sciences and industrial customers around the globe. Across 80 locations and 10,000 people worldwide, we are unified by a singular drive: to solve our customers' biggest fluid management challenges. And in doing so advance health, safety, and environmentally responsible technologies. Together, our Life Sciences and Industrial teams serve a diverse range of customers including biotechnology, pharmaceutical, medical, food and beverage, laboratory, microelectronics, aerospace, fuels, petrochemical, chemical, automotive and power generation industries. Our industry-leading technologies and solutions are at work in countless applications, protecting critical operating assets, improving product quality, safeguarding the health, and minimizing emissions and waste
For more info, please check: https://www.pall.com/en/biotech.html
We deliver and implement rapid and cost-effective Biomanufacturing solutions from early phase development through scale-up to commercial manufacturing. Benefit from the most comprehensive bioprocess technology portfolio coupled with our expertise in Single-use bioprocess engineering. Our global bioprocess teams are available to discuss your process development and manufacturing requirements.
Datwyler is a leading industrial supplier and a key player in the global health care world.
Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our healthcare offering, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum
seals, and processing technologies. Partnering up with the world’s top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure all patient’s safety and improve patients’ lives.
For more infromation, please visit: https://datwyler.com/
Ami Polymer Pvt. Ltd. is one of the leading manufacturers and suppliers of Biopharmaceuticals and silicone-based products in India . Established in the year 1998 in Mumbai, India, our company has been acclaimed for quality and excellence in the range of products offered. We employ efficient supply chain management system and have committed ourselves to deliver the finest products on time to our valuable customers.
We are an ISO 9001:2015,ISO 14001:2015 & ISO 45000-2018 ,TUV Nord Certified company, having a cleanroom of 25000 sq. feet area, supplying the finest quality range of biopharmaceuticals grade Elastomer Tubing, Reinforced Hoses, Inflatable Gaskets, Extruded & moulded components and single use assemblies as per USFDA standards.
Know more about us at :- www.amipolymer.com
Primary Contact :- Mr. Chandan S./Mrs. Aswathy Nair
Email id :- email@example.comfirstname.lastname@example.org
Designation :- Sr. Manager Business Devlopment / Sr. Executive International Marketing
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 40 billion components and devices each year.
Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2020 generated over $2.147 billion in annual revenue. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.
Our Purpose is to use our Smart science to improve lives™. We combine our knowledge, passion, and entrepreneurial spirit to create, make, and sell sustainable speciality ingredients that are relied upon by industries and consumers everywhere since 1925.
For nearly a hundred years, Croda has been a world-leading specialist for high-quality pharmaceutical excipients and vaccine adjuvants, serving the major human vaccines and medication producers globally. Today, we supply adjuvants and high purity pharmaceutical excipients to 12 of the 19 currently approved Covid-19 vaccines.
To learn more about what Croda Health Care offers, visit us at: https://bit.ly/3r4hn6z
Roquette is a global leader in plant-based ingredients, a pioneer of plant proteins and a leading provider of pharmaceutical excipients. The group addresses current and future societal challenges by unlocking the potential of nature to offer the best ingredients for food, nutrition and health markets. In collaboration with customers who are also passionate about the ongoing food revolution, Roquette contributes to developing a whole new gastronomy that meets consumers’ demands. In the pharma sector, Roquette offers solutions that play a critical role in medical treatments that cure and save lives. Thanks to a constant drive for innovation and a long-term vision, the group is committed to improving the well-being of millions of people all over the world while taking care of resources and territories. Founded in 1933, Roquette is a family-owned company which operates in more than 100 countries, has a turnover of around 3.5 billion euros, and employs 8,360 people worldwide.
- link to website - https://www.roquette.com/
Shimadzu Corporation, Japan founded in 1875 and having a history of more than 145 years, is one of the leading Manufacturers & suppliers of Analytical, scientific & testing instruments such as Chromatography, Mass-Spectrometry, Spectroscopy, Testing instruments, Environmental monitoring instruments. Shimadzu Analytical (India) Pvt Ltd, a wholly owned subsidiary of Shimadzu Corporation, Japan, offers an extensive range of instruments, value added services & customer support.
Shimadzu has been serving the Indian scientific community since many decades now, through its well-established network of distributors namely Toshvin Analytical, Spinco Biotech, Swan Environmental, Amkette Analytics & Perfomax Analytical for various product ranges.
The Customer Support Centres (CSC) in India were established in Mumbai (2006) & New Delhi (2008) to reaffirm the commitment towards our valued customers. Our state-of-art facility showcases a wide range of analytical instruments with the key objective of providing application support & continuous technical training for analytical scientists to offer the best possible solutions to face the challenges faced by the analysts.
SKAN is a Swiss company and a global market and technological leader for isolators and decontamination processes for the aseptic production of biopharmaceutical substances. SKAN’s core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products.
Pharmalab has allied with SKAN to provide the technological advantages of isolator technology to the Indian pharma and biotech industry. Our focus is to offer the complete solution from basic design (DQ) via construction to complete qualification (PQ) of this state-of-the-art technology to all our customers in the Indian region.
Aeris dynamics packaging was established in Singapore in the year 2001. We are specializing in research, design, test, manufacture, validation, and implementation of cold chain insulated packaging system for the pharmaceuticals, biomedical science, vaccine, clinical trials, medical, diagnostics and healthcare markets.
Aeris now offers it service from 9 locations India, Singapore, Malaysia, South Korea, China, Thailand, Hong Kong, Gulf and Australia. Aeris offers both standard and customize shipping system designed to ensure the integrity upon arrival of sensitive vaccines, drugs enzymes, blood, diagnostic specimens, and other associated products.
Aeris dynamics products are manufactured to cater for industries requirements meeting stringent shipping regulations as well as in reference to the guidance by leading industries and government bodies such as the FDA, WHO, IATA and ISTA.
Our vision is to be the leading global supply partner for cold chain temperature-controlled packaging. Our mission through our product and service excellence by technological innovation is to become the preferred choice of cold chain packaging solutions supply partner.
ACROBiosystems is a leading manufacturer of recombinant proteins and other critical reagents to support the development of target therapeutics, vaccines, and diagnostics. The company employs an application-oriented development strategy, with a particular focus on product design, quality control and solution-based support. Our products and services enable anyone in the field of drug development to have a more intuitive and streamlined process.
ACROBiosystems' catalog includes a comprehensive list of disease-associated biomarkers and drug targets from humans to other common species. All of our products are produced with high quality and batch-to-batch consistency to satisfy the rigorous standards of pharmaceutical research and development.
As ACROBiosystems' only distributor in India, Allianz BioInnovation is an ISO 9001: 2015 Certified Biotech company offering innovative Life Science Research tools from renowned companies across the world who are world leaders in their respective fields. The company has gained recognition, success and growth to its present position of a leading distributor as a result of our focus on scientist’s research needs and by following three principle viz; value, service and support.
URL link/website: https://www.acrobiosystems.com/
Adapt builds cloud-connected data loggers for cold chain monitoring.
Adapt loggers is established to support active cold chain operations with real-time asset intelligence data, which is essential to curb the losses.
Asset tracking, Logistics, Cold-chain, Biopharma, Food, and Cold storage companies use Adapt solutions to track and monitor their operations.
The patented end-to-end monitoring solutions give real-time status reports of the asset's location, temperature, humidity, tampering, and mishandlingAdapt provides Cloud storage and a Web-App interface for real-time data access and ease of reporting.
URL or link to your website:
Terumo Pharmaceutical Solutions develops patient-oriented parenteral delivery solutions for therapeutic performance and safety
Globally trusted for quality and precision, Terumo Pharmaceutical Solutions offers pharmaceutical and medical device manufacturers around the world comprehensive product design and development services.
We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral drug delivery.
Innovation and creativity are central to our value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for all parenteral applications.We listen. We question. We deliver.
Nanghavi is a Joint Venture between Sweden based R&D company Nanologica and an Indian family owned business by the Sanghavi family, thereby deriving the name “NANGHAVI”.
We are in the business of manufacturing Analytical, Semi Preparative and Prep HPLC columns by. Our in-house capabilities boasts of manufacturing the silica, functionalizing it, packing the HPLC column & marketing and selling them.
We have an end-to-end capability of manufacturing from the raw material of spherical silica to the HPLC columns itself, we can have complete control over quality of the end product.
Pfanstiehl is the market leader of high purity, low endotoxin, low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all leading global biopharmaceutical companies.
Pfanstiehl was founded in 1919 and currently celebrating its 103rd anniversary year in 2022. Pfanstiehl is headquartered at Waukegan, IL, USA and has diverse global technical support team across the globe in USA, Europe & APAC.
Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s high purity, low endotoxin and low metal excipient products are known as “best in class” due to their high characterization, performance, consistency, and quality attributes.
Pfanstiehl’s excipients are critical components in the majority of the global blockbuster biopharmaceutical drugs and vaccines including majority of the Covid -19 vaccines that were administered globally.
A world leader in the design and manufacture of high-performance temperature-controlled packaging systems for the transport of pharmaceutical products, EMBALL’ISO is now an expert of turnkey Reuse, Reverse Logistics and Rental solutions.
EMBALL’ISO’s worldwide presence across 4 continents, with 8 production sites (Brazil, China, France, Germany, India, Singapore, UK and the US), 14 Services Centre and collection points in more than 80 countries helps you reuse isothermal packaging while saving time and money.
We supply systems capable of carrying a single vial to airfreight pallet shippers available flat packed or fully assembled in new and innovative Logistics Business models.
EMBALL’ISO delivers quality everywhere, just like you.
- The 3M biopharmaceutical business is a subset of the 3M Separation and Purification Sciences Division which utilizes cutting edge 3M material science that pushes the boundaries of purification, filtration, and separation to support production, processes that change lives, and deliver quality solutions where it matters most.
- Our biopharma and materials science expertise can help you improve in-process purity, increase the yield of your product and lower manufacturing costs – so you can focus on bringing life-saving treatments to trial and market
- Biopharmaceutical Purification | 3M
Marken is a wholly owned subsidiary of UPS and is a critical part of UPS Healthcare. With Polar Speed and Marken included, the UPS Healthcare division staffs 128 locations with 5,500 employees worldwide. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 59 locations worldwide, while maintaining the leading position for Direct-to-Patient and Home Healthcare services, biological sample shipments and biological kit production.
Marken’s dedicated 2,000 staff members manage 135,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries and territories and have orchestrated 11,500+ home healthcare visits. Additional services such as cell and gene supply chain services, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.
HiMedia Laboratories Private Limited is an Indian origin Bioscience company headquartered in Mumbai, with presence across 150 countries. Its division, Animal Cell Culture has expertise in production of cell culture medium for mammalian & insect cell lines, in powdered and liquid formulations. Comprehensive design of experiments, raw material qualification and media production using automation and customization are our strengths. We supply serum free media for CHO, Vero, MDCK, HEK, PK-15, Vero, MRC-5 and BHK cell lines, most widely used for industrial production of recombinant proteins and vaccines. In addition, we also supply multi-compendial biochemicals and growth factors for Cell Culture.
To know more about our company please visit our website: www.himedialabs.com
Peli BioThermal is the first cold chain packaging solutions provider to make available a broad and comprehensive portfolio of patented and award-winning single-use and reusable thermal protection packaging solutions for the safe transport of pharmaceuticals, clinical trials, diagnostics, tissue, vaccines and blood supplies for the life science industry.
Collaboration with our clients is the first step to ensure we provide a solution that is built around the unique and very specific needs of your temperature-sensitive payloads. Our global services network provides consultation, support, engineering and deployment for your cold chain distribution challenges wherever they exist.
Peli BioThermal designs products to ensure our customers valuable payloads are kept in perfect condition, irrespective of external temperatures and conditions. They are designed to be strong and robust, to survive the rigors of international transport. With environmental issues in mind, we ensure that our design team specify the correct materials and consider ‘end of life’ recycling for all of our ranges, whether they are single use or reusable packaging systems.
The world’s first “Vial-to-Harvest” Vaccine manufacturing platform with Linear scalability & ultimate process efficiency.
With decades of developmental efforts & experience in Bioprocess Engineering, we have solved the most critical problems of adherent cell culture processing i.e. 1) Lack of process scalability 2) Efficiency in terms of time to market 3) Affordability in terms of cost reduction in manufacturing process.
At OmniBRx, we have invented a novel bioreactor technology for large-scale biologics / vaccines production and stem-cell therapy use. The technology provides 10X Scalability, 6X efficiency and up to 90% cost reduction during upstream manufacturing processing.
Our patented “CellBRx®️” single-use bioreactors technology is the first-of-its-kind bioreactor devices offering a fully automated and robust platform for vaccine manufacturing with linear scalability of up to 200L bioreactor volume accommodating 1500 m2 of surface area per single-use bioreactor. The proprietary DBR technology employs parallel discs stacked on multiple shafts and the intermingling rotational arrangement of the discs ensures efficient mixing and homogeneity throughout the cell carrier matrix.
With the integrated seed-train development protocol, the technology becomes the first ever close-circuit fully-automated Vial-to-Harvest production platform. The CellBRx bioreactors can grow cells in high densities and recover them efficiently with complete end-to-end process automation.
Past Supporting Partners
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.
Express Healthcare, first published as Express Healthcare Management in January 2000, has grown to become the No.1 Business News Magazine for the healthcare industry. The editorial contents include: news, views, analysis and interviews, under main segments: Market, Strategy, Knowledge, Life, Radiology, Hospital Infra, IT@Healthcare. Besides this, we bring out a quarterly publication, called In Imaging for the radiology and imaging segment.
Cold Chain Platform (CCP) is 100% focused on cold chain and logistics in the biopharmaceutical, life science, and healthcare industries. CCP services help global companies reach the right partners and get a firm foothold in the Asia Pacific. CCP works with global organizations to help them gain access to the APAC cold chain, logistics, and pharmaceutical market through a highly targeted audience.
DBT/Wellcome Trust India Alliance (India Alliance) is an independent, dynamic public charity that funds research in health and biomedical sciences in India. India Alliance invests in transformative ideas and supportive research ecosystems to advance discovery and innovation to improve health and well-being. India Alliance encourages diversity, inclusivity, and transparency in science and works to facilitate engagement of science with society.
BioPharma Asia aims to keep its readers abreast of all developments in the areas of Manufacturing, Development, Quality Assurance, Outsourcing, and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters, associated with only end-user companies. This ensures that the information will always be guaranteed to remain timely, informative and above all totally unbiased.
Present your expertise to the key vaccines stakeholders from developing economies through a variety of available speaking packages.
Join the exhibition, and build an impressive presence among your potential clients.
Emphasize on your messages by promoting your brand alongside exhibition and thought leadership.
Engage with and build lasting connections that matter the most to your business.
Gain exclusive access to contacts of high-profile attendees through intimate networking opportunities.